Family · Pharmaceutical analytical standards
Sunifiram
A research compound with a piperazine structure (DM-235), described around 2000 as a molecular simplification of unifiram: in animals it showed anti-amnesic effects, but as of 2016 it had not been tested in humans or approved. This family brings together the active ingredient.
Did you know?Its mechanism remains a puzzle: it does not bind appreciably to the main receptors, channels and transporters, yet its effects depend on the glycine site of NMDA receptors.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
